Patent details

EP3490580 Title: NTP PEPTIDES FOR USE IN PREVENTING OR REDUCING THE INCIDENCE OF ACUTE URINARY RETENTION

Basic Information

Publication number:
EP3490580
PCT Application Number:
IB2017054277
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP177461977
PCT Publication Number:
WO2018020355
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
NTP PEPTIDES FOR USE IN PREVENTING OR REDUCING THE INCIDENCE OF ACUTE URINARY RETENTION
French Title of Invention:
PEPTIDES DE NTP POUR L'UTILISATION DANS LE PRÉVENTION OU RÉDUCTION DE L'INCIDENCE DE LA RÉTENTION URINAIRE AIGUË
German Title of Invention:
NTP PEPTIDE IN DER VERWENDUNG ZUR VERHINDERUNG ODER REDUZIERUNG DES AUFTRETENS VON AKUTEM HARNVERHALT
SPC Number:

Dates

Filing date:
14/07/2017
Grant date:
25/08/2021
EP Publication Date:
05/06/2019
PCT Publication Date:
01/02/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
25/08/2021
EP B1 Publication Date:
25/08/2021
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
14/07/2022
Expiration date:
14/07/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
18/08/2021
 
 

Name:
Nymox Corporation
Address:
777 Terrace Avenue, Hasbrouck Heights, New Jersey 07604, United States (US)

Inventor

Name:
AVERBACK, Paul
Address:
Bahamas (BS)

Priority

Priority Number:
201615222365
Priority Date:
28/07/2016
Priority Country:
United States (US)

Classification

IPC classification:
A61K 38/10; A61K 31/517; A61P 13/02;

Publication

European Patent Bulletin

Issue number:
202134
Publication date:
25/08/2021
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages